Payman Arabzadeh, MD
Family Medicine · Magnolia, TXNPI 1124075510
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,190 of the $1,713 with a category attached, or 69.5%. AbbVie accounts for 80.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $910 and has fallen 87.4% since, to $114 in 2025.
Across 22 payments — averaging $77.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$120
- Genentech USA, Inc.$120
- Abbott$45
- Paratek Pharmaceuticals, Inc.$40
- Galderma Laboratories, L.p.$14
What the payments were for
- Speaking & faculty fees$52331%
- Food & beverage$1,19069%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $1,375 |
| Lilly USA, LLC | 1 | $120 |
| Genentech USA, Inc. | 1 | $120 |
| Abbott | 1 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,713 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 16 | $97 |
| Doxycycline Hyclate | 13 | $94 |
| Azithromycin | 19 | $60 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Magnolia
- Feras ElhajjMagnolia$37K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.